Common Name2-deoxy-alpha-d-ribose 1-phosphate
DescriptionDeoxyribose 1-phosphate is an intermediate in the metabolism of Pyrimidine. It is a substrate for Purine nucleoside phosphorylase and Thymidine phosphorylase.
Structure
Molecular FormulaC5H11O7P
Average Mass214.11040
Monoisotopic Mass214.02424
IUPAC Name{[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}phosphonic acid
Traditional Name[(4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphosphonic acid
CAS Registry Number17210-42-3
SMILESO=P([O-])([O-])O[C@@H]1C[C@H](O)[C@@H](CO)O1
InChI IdentifierInChI=1S/C5H11O7P/c6-2-4-3(7)1-5(11-4)12-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/t3-,4+,5?/m0/s1
InChI KeyKBDKAJNTYKVSEK-PYHARJCCSA-N
CHEBI IDCHEBI:57259
HMDB IDHMDB0001351
Pathways
NameSMPDB/PathBank
Pyrimidine metabolism
pentose phosphate pathway
Purine metabolism
Adenosine Deaminase Deficiency
Adenylosuccinate Lyase Deficiency
AICA-Ribosiduria
Beta Ureidopropionase Deficiency
Dihydropyrimidinase Deficiency
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)
Molybdenum Cofactor Deficiency
Purine Nucleoside Phosphorylase Deficiency
UMP Synthase Deficiency (Orotic Aciduria)
Xanthine Dehydrogenase Deficiency (Xanthinuria)
Lesch-Nyhan Syndrome (LNS)
Gout or Kelley-Seegmiller Syndrome
Azathioprine Action Pathway
Mercaptopurine Action Pathway
Thioguanine Action Pathway
Xanthinuria type I
Xanthinuria type II
Glucose-6-phosphate dehydrogenase deficiency
Ribose-5-phosphate isomerase deficiency
Transaldolase deficiency
Adenine phosphoribosyltransferase deficiency (APRT)
Mitochondrial DNA depletion syndrome
Myoadenylate deaminase deficiency
StateSolid
Water Solubility3.76e+01 g/l
logP-2.14
logS-0.76
pKa (Strongest Acidic)1.37
pKa (Strongest Basic)-2.98
Hydrogen Acceptor Count6
Hydrogen Donor Count4
Polar Surface Area116.45 Ų
Rotatable Bond Count3
Physiological Charge-2
Formal Charge0
Refractivity39.32 m³·mol⁻¹
Polarizability17.21

We require the use of cookies for essential features like storing your previously submitted BASys2 queries. Rejecting the usage of cookies will result in certain features being disabled. By clicking ACCEPT or continuing to use the website you are agreeing to our use of cookies.

ACCEPT